Association Between Diabetes During Pregnancy and Peripartum Cardiomyopathy: A Population-Level Analysis of 309,825 Women

Canadian Journal of Cardiology

Volumn 33, Issue 7, 2017, Pages 911-917

  Dhesi, Sumandeep ^a   Savu, Anamaria ^b   Ezekowitz, Justin A ^b   Kaul, Padma ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; BIRTH WEIGHT; CESAREAN SECTION; COHORT ANALYSIS; DIABETES MELLITUS; ECLAMPSIA; FEMALE; FOLLOW UP; HUMAN; LABOR INDUCTION; MAJOR CLINICAL STUDY; MATERNAL DEATH; MATERNAL DIABETES MELLITUS; MATERNAL HYPERTENSION; MORTALITY RATE; NEWBORN DEATH; OUTCOME ASSESSMENT; PERIPARTUM CARDIOMYOPATHY; PREECLAMPSIA; PREGNANCY; PREMATURITY; PRIMIPARA; PUERPERIUM; ALBERTA; CARDIOMYOPATHY, DILATED; CLINICAL TRIAL; HEALTH SURVEY; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; NEWBORN; PERINATAL PERIOD; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; ALBERTA; CARDIOMYOPATHY, DILATED; DIABETES MELLITUS; FEMALE; HUMANS; INCIDENCE; INFANT, NEWBORN; MIDDLE AGED; PERIPARTUM PERIOD; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY IN DIABETICS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 85019572168     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2017.02.008     Document Type: Article

References (30)

1. Pearson, G.D., Veille, J.C., Rahimtoola, S., et al. Peripartum Cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 283 (2000), 1183–1188.
2. Sliwa, K., Hilfiker-Kleiner, D., Petrie, M.C., et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 12 (2010), 767–778.
3. Lampert, M.B., Lang, R.M., Peripartum cardiomyopathy. Am Heart J 130 (1995), 860–870.
4. Elkayam, U., Akhter, M.W., Singh, H., et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 111 (2005), 2050–2055.
5. Sliwa, K., Damasceno, A., Mayosi, B.M., Epidemiology and etiology of cardiomyopathy in Africa. Circulation 112 (2005), 3577–3583.
6. Mielniczuk, L.M., Williams, K., Davis, D.R., et al. Frequency of peripartum cardiomyopathy. Am J Cardiol 97 (2006), 1765–1768.
7. Brar, S.S., Khan, S.S., Sandhu, G.K., et al. Incidence, mortality, and racial differences in peripartum cardiomyopathy. Am J Cardiol 100 (2007), 302–304.
8. Gentry, M.B., Dias, J.K., Luis, A., et al. African-American women have a higher risk for developing peripartum cardiomyopathy. J Am Coll Cardiol 55 (2010), 654–659.
9. Elkayam, U., Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management. J Am Coll Cardiol 58 (2011), 659–670.
10. Habli, M., O'Brien, T., Nowack, E., et al. Peripartum cardiomyopathy: prognostic factors for long-term maternal outcome. Am J Obstet Gynecol 199 (2008), 415.e1–415.e5.
11. Kolte, D., Khera, S., Aronow, W.S., et al. Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study. J Am Heart Assoc, 3, 2014, e001056.
12. McNamara, D.M., Elkayam, U., Alharethi, R., et al. Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy). J Am Coll Cardiol 66 (2015), 905–914.
13. Statistics Canada. Available at: http://www.statcan.gc.ca/ Accessed September 21, 2015.
14. Quan, H., Li, B., Saunders, L.D., Parsons, G.A., et al. Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database. Health Serv Res 43 (2008), 1424–1441.
15. So, L., Evans, D., Quan, H., ICD-10 coding algorithms for defining comorbidities of acute myocardial infarction. BMC Health Serv Res, 6, 2006, 161.
16. Ingelsson, E., Arnlov, J., Sundstrom, J., Lind, L., The validity of a diagnosis of heart failure in a hospital discharge register. Eur J Heart Fail 7 (2005), 787–791.
17. Witlin, A.G., Mabie, W.C., Sibai, B.M., Peripartum cardiomyopathy: an ominous diagnosis. Am J Obstet Gynecol 176 (1997), 182–188.
18. Chapa, J.B., Heiberger, H.B., Weinert, L., et al. Prognostic value of echocardiography in peripartum cardiomyopathy. Obstet Gynecol 105 (2005), 1303–1308.
19. Demakis, J.G., Rahimtoola, S.H., Sutton, G.C., et al. Natural course of peripartum cardiomyopathy. Circulation 44:6 (1971), 1053–1061.
20. Seftel, H., Susser, M., Maternity and myocardial failure in African women. Br Heart J 23 (1961), 43–52.
21. Johnstone, M.T., Creager, S.J., Scales, K.M., et al. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 88 (1993), 2510–2516.
22. Bucala, R., Tracey, K.J., Cerami, A., Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes. J Clin Invest 87 (1991), 432–438.
23. Yoon, Y.S., Uchida, S., Masuo, O., et al. Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor. Circulation 111 (2005), 2073–2085.
24. Patten, I.S., Rana, S., Shahul, S., et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature 485 (2012), 333–338.
25. Damp, J., Givertz, M.M., Semigran, M., et al. Relaxin-2 and soluble Flt1 levels in peripartum cardiomyopathy. JACC Heart Fail 4 (2016), 380–388.
26. Hilfiker-Kleiner, D., Haghikia, A., Nonhoff, J., Bauersachs, J., Peripartum cardiomyopathy: current management and future perspectives. Eur Heart J 36 (2015), 1090–1097.
27. Howlett, J.G., McKelvie, R.S., Costigan, J., et al. The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs. Can J Cardiol 26 (2010), 185–202.
28. Forster, O., Hilfiker-Kleiner, D., Ansari, A.A., et al. Reversal of IFN-gamma, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy. Eur J Heart Fail 10 (2008), 861–868.
29. Sliwa, K., Skudicky, D., Bergemann, A., et al. Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. J Am Coll Cardiol 35 (2000), 701–705.
30. Desplantie, O., Tremblay-Gravel, M., Avram, R., et al. The medical treatment of new-onset peripartum cardiomyopathy: a systematic review of prospective studies. Can J Cardiol 31 (2015), 1421–1426.